Autoimmune hepatitis: 50 years of (slow) progress

Hepatology

Volumn 59, Issue 3, 2014, Pages 754-756

  Gershwin, M Eric ^a   Krawitt, Edward L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; CD4 ANTIGEN; EPITOPE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE E3;

ACUTE GRAFT REJECTION; ALCOHOL LIVER DISEASE; ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CATALYSIS; CELL FUNCTION; CELL POPULATION; CELLULAR IMMUNITY; CHRONIC HEPATITIS; DIAGNOSTIC KIT; DIZYGOTIC TWINS; EDITORIAL; EFFECTOR CELL; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; GENDER BIAS; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HEREDITY; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; LIVER DISEASE; LUPOID HEPATITIS; METABOLOMICS; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; PUBLICATION; RECOMBINANT DNA TECHNOLOGY; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SCLEROSING CHOLANGITIS; SEROLOGY; SPATIAL ORIENTATION; SUPPRESSOR CELL; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL DEPLETION; T LYMPHOCYTE; TREATMENT RESPONSE;

ANTIGENS, CD; APYRASE; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84896711879     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26682     Document Type: Editorial

References (17)

1. Mackay IR, Burnet FM. Autoimmune diseases: pathogenesis, chemistry and therapy. Springfield, IL: Charles C. Thomas; 1963.
2. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54:374-385.
3. Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 2013;41:140-145.
4. Mackay IR, Morris PJ. Association of autoimmune active chronic hepatitis with HL-A1, 8. Lancet 1972;2:793-795.
5. Yokosawa S, Yoshizawa K, Ota M, Katsuyama Y, Kawa S, Ichijo T, et al. A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1. Hepatology 2007;45:384-390.
6. Lankisch TO, Mourier O, Sokal EM, Habes D, Lacaille F, Bridoux-Henno L, et al. AIRE gene analysis in children with autoimmune hepatitis type I or II. J Pediatr Gastroenterol Nutr 2009;48:498-500.
7. Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C, et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012;38:J156-169.
8. Ohira H, Shinzawa J, Suzuki T, Tojo J, Sato H, Nishimaki T, et al. Two sister cases of autoimmune hepatitis. Fukushima J Med Sci 1998;44:113-120.
9. pos regulatory T cells and aberrant control of T helper type 17 cells in autoimmune hepatitis. Hepatology 2014;59:1007-1015.
10. Krawitt EL, Kilby AE, Albertini RJ, Schanfield MS, Chastenay BF, Harper PC, et al. An immunogenetic study of suppressor cell activity in autoimmune chronic active hepatitis. Clin Immunol Immunopathol 1988;46:249-257.
11. Liberal R, Grant CR, Holder BS, Ma Y, Mieli-Vergani G, Vergani D, et al. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology 2012;56:677-686.
12. Longhi MS, Liberal R, Holder B, Robson SC, Ma Y, Mieli-Vergani G, et al. Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology 2012;142:1526-1535 e1526.
13. Longhi MS, Robson SC, Bernstein SH, Serra S, Deaglio S. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. J Mol Med (Berl) 2013;91:165-172.
14. Bonito AJ, Aloman C, Fiel MI, Danzl NM, Cha S, Weinstein EG, et al. Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest 2013;123:3510-3524.
15. Rudra D, deRoos P, Chaudhry A, Niec RE, Arvey A, Samstein RM, et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 2012;13:1010-1019.
16. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525-3531.
17. Suthanthiran M, Schwartz JE, Ding R, Abecassis M, Dadhania D, Samstein B, et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 2013;369:20-31.